131 related articles for article (PubMed ID: 6091148)
1. Complement-requiring neutralizing antibody in guinea pigs with primary and recurrent genital herpes.
Zheng ZM; Hsiung GD
Proc Soc Exp Biol Med; 1984 Nov; 177(2):332-6. PubMed ID: 6091148
[TBL] [Abstract][Full Text] [Related]
2. Antibody response to the herpes simplex virus type 2 AG-4 antigen in guinea pigs with genital herpes infections.
Maragos C; Miller A; May JT
Aust J Exp Biol Med Sci; 1986 Feb; 64 ( Pt 1)():89-95. PubMed ID: 3008691
[TBL] [Abstract][Full Text] [Related]
3. Antibody response to herpes simplex virus glycoprotein D: effects of acyclovir and relation to recurrence.
Bernstein DI; Stanberry LR; Harrison CJ; Shukla R; Kappes JC; Myers MG
J Infect Dis; 1987 Sep; 156(3):423-9. PubMed ID: 3039009
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing antibody to herpes simplex in pregnant women and their neonates.
Harger JH; Guevarra L; Armstrong JA
J Perinatol; 1990 Mar; 10(1):16-9. PubMed ID: 2156030
[TBL] [Abstract][Full Text] [Related]
5. Studies on the neutralization of herpes simplex virus. X. Demonstration of complement-requiring neutralizing (CRN) and slow-reacting CRN (s-CRN) antibodies in late IgG.
Yoshino K; Isono N; Tada A; Urayama M
Microbiol Immunol; 1979; 23(10):975-85. PubMed ID: 229389
[TBL] [Abstract][Full Text] [Related]
6. Regulation by recombinant interleukin-2 of protective immunity against recurrent herpes simplex virus type 2 genital infection in guinea pigs.
Weinberg A; Konrad M; Merigan TC
J Virol; 1987 Jul; 61(7):2120-7. PubMed ID: 3035213
[TBL] [Abstract][Full Text] [Related]
7. Complement requirement of neutralizing antibodies in different classes of immunoglobulin appearing in rabbits and guinea pigs after primary and booster immunizations with herpes simplex virus.
Shinkai K; Yoshino K
Jpn J Microbiol; 1975 Feb; 19(1):25-34. PubMed ID: 169417
[TBL] [Abstract][Full Text] [Related]
8. Vaccine induced HSV 1 antibodies fail to correlate with protection against HSV 2 in guinea pigs.
Welch MJ; Ridgeway PH; Phillpotts RJ
FEMS Microbiol Immunol; 1988 Dec; 1(3):157-62. PubMed ID: 2856207
[TBL] [Abstract][Full Text] [Related]
9. Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.
Blevins TP; Mitchell MC; Korom M; Wang H; Yu Y; Morrison LA; Belshe RB
PLoS One; 2015; 10(12):e0144738. PubMed ID: 26658766
[TBL] [Abstract][Full Text] [Related]
10. Studies on the neutralization of herpes simplex virus. XI. Differences between slow-reacting complement-requiring neutralizing (s-CRN) antibodies in IgG and IgM.
Yoshino K; Urayama M; Abe K
Microbiol Immunol; 1980; 24(11):1069-77. PubMed ID: 6261091
[TBL] [Abstract][Full Text] [Related]
11. A new microplate neutralization test for typing of herpes simplex virus.
Tada A; Yoshino K
Microbiol Immunol; 1978; 22(7):415-26. PubMed ID: 213699
[TBL] [Abstract][Full Text] [Related]
12. A micro-neutralization system for detection of s-CRN antibody to herpes simplex virus.
Yoshino K; Abe K
Microbiol Immunol; 1981; 25(10):1037-46. PubMed ID: 6273697
[TBL] [Abstract][Full Text] [Related]
13. Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection.
Sherlock CH; Ashley RL; Shurtleff ML; Mack KD; Corey L
J Clin Microbiol; 1986 Dec; 24(6):1093-7. PubMed ID: 3023439
[TBL] [Abstract][Full Text] [Related]
14. Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir.
Bernstein DI; Stanberry LR; Harrison CJ; Kappes JC; Myers MG
J Gen Virol; 1986 Aug; 67 ( Pt 8)():1601-12. PubMed ID: 3016155
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of herpes simplex virus by antibody in amniotic fluid.
Bradley JS; Yeager AS; Dyson DC; Hensleigh PA; Medearis AL
Obstet Gynecol; 1982 Sep; 60(3):318-21. PubMed ID: 6289206
[TBL] [Abstract][Full Text] [Related]
16. Confirmation of herpes simplex virus type 2 infections in herpes-like genital lesions by a simple complement-fixation test.
Arsenakis M; May JT
Br J Vener Dis; 1982 Feb; 58(1):48-51. PubMed ID: 6275941
[TBL] [Abstract][Full Text] [Related]
17. Recurrent genital herpes simplex virus infection in guinea pigs.
Stanberry LR; Kern ER; Richards JT; Overall JC
Intervirology; 1985; 24(4):226-31. PubMed ID: 3000982
[TBL] [Abstract][Full Text] [Related]
18. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
Nemerow GR; Jensen FC; Cooper NR
J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
[TBL] [Abstract][Full Text] [Related]
19. Studies on the neutralizing antibody to herpes simplex virus. III. Detection of type-specific antibody by slow-reacting complement-requiring neutralizing antibody assay.
Ohashi M; Ozaki Y
Microbiol Immunol; 1982; 26(7):569-74. PubMed ID: 7132789
[TBL] [Abstract][Full Text] [Related]
20. Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection.
Bernstein DI; Tepe ER; Mester JC; Arnold RL; Stanberry LR; Higgins T
Vaccine; 1999 Apr; 17(15-16):1964-9. PubMed ID: 10217595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
